APA (7th ed.) Citation

Bitler, B., Woodruff, E., Kostka-Newman, Z., Garcia, J. R. M., Merino-Hsieh, A., Kusumoto, S., . . . Lang, J. (2026). Combining p38 Inhibition with chemotherapy promotes T-cell infiltration and limits growth of therapy resistant high grade serous carcinoma tumors. Gynecologic Oncology, 208, S395. https://doi.org/10.1016/j.ygyno.2026.01.681

Chicago Style (17th ed.) Citation

Bitler, Benjamin, Elizabeth Woodruff, Zander Kostka-Newman, John Rhey Mhar Garcia, Alba Merino-Hsieh, Shinya Kusumoto, Sandra Orsulic, Nicole Marjon, and Julie Lang. "Combining P38 Inhibition with Chemotherapy Promotes T-cell Infiltration and Limits Growth of Therapy Resistant High Grade Serous Carcinoma Tumors." Gynecologic Oncology 208 (2026): S395. https://doi.org/10.1016/j.ygyno.2026.01.681.

MLA (9th ed.) Citation

Bitler, Benjamin, et al. "Combining P38 Inhibition with Chemotherapy Promotes T-cell Infiltration and Limits Growth of Therapy Resistant High Grade Serous Carcinoma Tumors." Gynecologic Oncology, vol. 208, 2026, p. S395, https://doi.org/10.1016/j.ygyno.2026.01.681.